Justice Department asks Supremes to weigh health law; Novartis launches Votubia in U.K.;

@FiercePharma: Pfizer tells Indian hand-wringers that drug-price controls mean M&A won't touch off runaway price hikes $PFE #pharma. News | Follow @FiercePharma

> The Obama administration has asked the Supreme Court to review its healthcare reform law in a sooner-than-expected move that could yield a decision by June. News

> Novartis ($NVS) has launched Votubia--its everolimus brand aimed at a type of benign brain tumors--in the U.K. after conditional approval from the European Medicines Agency. Item

> A U.S. judge has dismissed Sandoz's antitrust claims against Bayer, saying the Novartis generics unit failed to show Bayer monopolized the U.S. oral contraceptive market. Article

> Questcor Pharmaceuticals ($QCOR) was up more than 9% yesterday after preliminary sales data for its drug Acthar showed an increase of 13% over the second quarter and 160% year-over-year. Report

> Prescriptions for ADHD drugs such as Ritalin and Adderall continue to rise, but at a slower pace than in the past. Story

Biotech News

@FierceBiotech: Proximagen polishes its CNS rep with $16M Lundbeck deal. News | Follow @FierceBiotech

@RyanMFierce: Which women in biotech inspire you? Please tell us here @FierceBiotech: Item | Follow @RyanMFierce

@MaureenFierce: U.S. economic woes "leading to risky Rx practices." People skimping on meds, MD visits. Piece | Follow @MaureenFierce

> Open-source R&D advocates prep $150M cancer drug project. News 

> Which women in biotech inspire you? Article

> Proximagen polishes its CNS rep with $16M Lundbeck deal. Story

Vaccines News

> Gardasil bests Cervarix in cost effectiveness battle. News 

> Vaccine could reduce HIV to 'minor infection.' Report 

> Vaccines critical for controlling chronic diseases. Item 

> Prospective Alzheimer's vax homes in on amyloid delivery. News 

> Agenus encouraged by early HerpV results. Report 

 Manufacturing News

> GSK planning off-grid move for savings. Story 

> Chinese API maker gets stern FDA warning over cross-contamination. Article

> The downside of downsizing: playing it safe. News 

> Google AdWords ban keeps drug savings from U.S. poor. Report 

> Congress gets started on drug-takeback program. Item 

> Lean manufacturing lessons from Human Genome Sciences. Story

And Finally... New evidence that diabetes is somehow linked to colon cancer. Item

Suggested Articles

In a trial called Empacta, Roche's IL-6 inhibitor cut ventilator use, but didn't significantly cut the risk of death in COVID-19 pneumonia patients.

Takeda opens cell therapy center in Boston. Celltrion's COVID antibody passes early safety tests. BMS and Dr. Reddy's settle Revlimid patent dispute.

Officials in New York charged Johnson & Johnson with violating insurance laws with its opioid marketing.